Amid Cost Unknowns, MAOs Will Get 1.66% Pay Increase
Facing a host of cost-related unknowns, Medicare Advantage organizations next year will be working with a slightly higher-than-expected pay increase, although CMS in its final MA and Part D rate notice made no adjustments to directly account for the impact of COVID-19 or the expected influx of patients diagnosed with end-stage renal disease (ESRD). However, the permanent repeal of the Affordable Care Act health insurer fee (HIF) and an adjustment to the Total Beneficiary Cost (TBC) measure may help offset some of the associated costs.
CMS in the 2021 rate notice released April 6 estimated that plans on average can expect a reimbursement increase of 1.66%. This was better than CMS’s initial projection of 0.93% in February (RMA 2/20/20, p. 1) but lower than the healthy 2.53% pay increase plans got this year.
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile
